Skip to Content
MDPIMDPI

Advanced

ARMAdvances in Respiratory Medicine
PDF
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Case Report
  • Open Access

30 October 2017

6 Pages

Sarcoidosis-Associated Pulmonary Hypertension Treated with Sildenafil

,
,
,
,
,
,
,
,
and
1
1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
2
Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
3
Department of Respiratory Physiopathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
4
Department of Cardiovascular and Pulmonary Thromboembolic Diseases CMKP, European Health Centre Otwock, Otwock, Poland
Adv. Respir. Med.2017, 85(5), 258-263;https://doi.org/10.5603/ARM.a2017.0043
Version Notes
Order Reprints

Abstract

Development of sarcoidosis-associated pulmonary hypertension (SAPH) significantly worsens prognosis in sarcoidosis patients. Unfortunately, there is no treatment of proven benefit for this condition. Medications used for treatment of pulmonary arterial hypertension are of great interest in this respect. Here, we report a case of a patient with severe SAPH treated with sildenafil. A significant, but only temporary improvement in functional status was observed, and the patient died of gradually progressing heart and respiratory failure while awaiting for lung transplantation.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Pulmonary Function Tests Leading to the Diagnosis of Vascular Malformations in School-Aged Children
Previous
Predictors of Noninvasive Ventilation Failure in Critically Ill Obese Patients: A Brief Narrative Review
Next